FDA Meeting on COVID Vaccine for Children

The Food and Drug Administration Advisory Committee met to discuss emergency use authorization for Pfizer’s COVID-19 vaccine in children… read more

The Food and Drug Administration Advisory Committee met to discuss emergency use authorization for Pfizer’s COVID-19 vaccine in children ages 5 to 11 years old. FDA and Centers for Disease Control and Prevention officials presented various data and topics, including the epidemiology of COVID-19 among children in this age group, post-COVID-19 symptoms, and vaccine dosage compared to older children. Pfizer officials presented clinical data on the safety and efficacy of the vaccine while FDA officials talked about their review of the submission. During the public meeting portion, the committee heard comments from the public, followed by an open discussion and vote on emergency use authorization. close

Report Video Issue

Points of Interest

For quick viewing, C-SPAN provides Points of Interest markers for some events.

Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.

Points of Interest

For quick viewing, C-SPAN provides Points of Interest markers for some events.

Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.

You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.

People in this video

  • Prabhakara Atreya Director U.S. Food and Drug Administration->Scientific Advisers and Consultants
  • Richard Forshee Associate Director U.S. Food and Drug Administration->Research
  • Peter W. Marks M.D. Director U.S. Food and Drug Administration->Center for Biologics Evaluation and Research
  • Leslie Ball M.D. Medical Officer U.S. Food and Drug Administration->Vaccines and Related Product Applications
  • Amanda Cohn Executive Secretary Advisory Committee on Immunization Practices
  • Doran Fink Deputy Director U.S. Food and Drug Administration->Vaccines and Related Biological Products Advisory Committee
  • Oveta Fuller Professor University of Michigan Medical School
  • Hayley Gans Professor Stanford University->Pediatric Infectious Diseases
  • William Gruber M.D. Senior Vice President Pfizer, Inc.->Vaccine Clinical Research and Development
  • Fiona Havers M.D. Medical Officer Centers for Disease Control and Prevention->National Center for Immunization and Respiratory Diseases
  • James Hildreth M.D. President and CEO Meharry Medical College
  • Michael Kurilla Director National Institutes of Health->Division of Clinical Innovation
  • Jeannette Lee Professor University of Arkansas->Biostatistics
  • Ofer Levy Director Boston Children's Hospital->Precision Vaccines Program
  • Cody Meissner Professor Tufts University->Infectious Diseases
  • Arnold Monto Professor University of Michigan->Epidemiology
  • Patrick Moore Professor University of Pittsburgh->Cancer Institute
  • Ramachandra Naik Chair U.S. Food and Drug Administration->Vaccines and Related Products Applications Committee
  • Michael Nelson M.D. Professor University of Virginia->Medical School
  • Paul Offit M.D. Director Children's Hospital of Philadelphia->Vaccination Education Center
  • Matthew Oster M.D. Associate Professor Emory University->School of Medicine
  • Steven Pergam Professor Fred Hutchinson Cancer Research Center
  • Stanley Perlman M.D. Professor University of Iowa->Immunology
  • Jay Portnoy Professor Children's Mercy Hospital->Pediatrics
  • Eric Rubin M.D. Editor in Chief New England Journal of Medicine
  • Mark Sawyer M.D. Specialist Rady Children's Hospital->Infectious Diseases
  • Melinda Wharton Director Centers for Disease Control and Prevention->Immunization Division
  • Hong Yang Senior Adviser U.S. Food and Drug Administration->Benefit-Risk Assessment Office
More People

Hosting Organization

More information about

FDA Meeting on COVID Vaccine for Children

5,916 Views
Program ID:
515531-1
Category:
Public Affairs Event
Format:
Meeting
Location:
Washington, District of Columbia, United States
First Aired:
Oct 26, 2021 | 8:30am EDT | C-SPAN 3
Last Aired:
Oct 27, 2021 | 5:16am EDT | C-SPAN 1

Airing Details

  • Oct 26, 2021 | 8:30am EDT | C-SPAN 3
  • Oct 26, 2021 | 1:37pm EDT | C-SPAN RADIO
  • Oct 26, 2021 | 2:14pm EDT | C-SPAN RADIO
  • Oct 26, 2021 | 6:28pm EDT | C-SPAN RADIO
  • Oct 26, 2021 | 8:25pm EDT | C-SPAN 2
  • Oct 26, 2021 | 10:41pm EDT | C-SPAN RADIO
  • Oct 27, 2021 | 3:27am EDT | C-SPAN 1
  • Oct 27, 2021 | 4:30am EDT | C-SPAN RADIO
  • Oct 27, 2021 | 5:16am EDT | C-SPAN 1

User Created Clips from This Video

View all clips from this video